Ana Oaknin

Home Tag

Ana-Oaknin-low-res-17-800x534

ESMO Clinical Practice Guideline: consensus recommendations & next directions in the treatment and follow-up of endometrial cancer

Now published in the European Society for Medical Oncology’s (ESMO) flagship journal, Annals of Oncology, ESMO’s Clinical Practice Guideline for…

Dra. Ana Oaknin

Under the spotlight: Nature Reviews Disease Primers illuminates the complexities of endometrial cancer & updates on recent advancements, emerging trends and therapeutic opportunities

Published last week in Nature Reviews Disease Primers, a comprehensive review* focused on endometrial cancer (EC) updates on the epidemiology,…

Dra. Ana Oaknin

Cemiplimab steps up as the first immune-based therapy to improve overall survival in patients with recurrent and/or metastatic cervical cancer

Barcelona, May 12, 2021- Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death…

ESMO

Newly appointed ESMO faculty: VHIO investigators join forces with other leading experts in oncology to deliver on ESMO’s Vision 2025

In parallel with the European Society for Medical Oncology’s (ESMO) publication of its 2025 Vision, which builds on the core…

WCD 2021

World Cancer Day 2021: saluting the strength of the cancer community through the COVID-19 pandemic

Thursday, February 04 2021, not only celebrates World Cancer Day’s 21st birthday but also the final year of its ‘I…